Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

Similar articles for PubMed (Select 25125497)

1.

Dengue virus infection induces broadly cross-reactive human IgM antibodies that recognize intact virions in humanized BLT-NSG mice.

Jaiswal S, Smith K, Ramirez A, Woda M, Pazoles P, Shultz LD, Greiner DL, Brehm MA, Mathew A.

Exp Biol Med (Maywood). 2015 Jan;240(1):67-78. doi: 10.1177/1535370214546273. Epub 2014 Aug 14.

PMID:
25125497
2.

Enhanced humoral and HLA-A2-restricted dengue virus-specific T-cell responses in humanized BLT NSG mice.

Jaiswal S, Pazoles P, Woda M, Shultz LD, Greiner DL, Brehm MA, Mathew A.

Immunology. 2012 Jul;136(3):334-43. doi: 10.1111/j.1365-2567.2012.03585.x.

3.

Utility of humanized BLT mice for analysis of dengue virus infection and antiviral drug testing.

Frias-Staheli N, Dorner M, Marukian S, Billerbeck E, Labitt RN, Rice CM, Ploss A.

J Virol. 2014 Feb;88(4):2205-18. doi: 10.1128/JVI.03085-13. Epub 2013 Dec 11.

4.

Isolation of dengue virus-specific memory B cells with live virus antigen from human subjects following natural infection reveals the presence of diverse novel functional groups of antibody clones.

Smith SA, de Alwis AR, Kose N, Jadi RS, de Silva AM, Crowe JE Jr.

J Virol. 2014 Nov;88(21):12233-41. doi: 10.1128/JVI.00247-14. Epub 2014 Aug 6.

5.

Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions.

de Alwis R, Smith SA, Olivarez NP, Messer WB, Huynh JP, Wahala WM, White LJ, Diamond MS, Baric RS, Crowe JE Jr, de Silva AM.

Proc Natl Acad Sci U S A. 2012 May 8;109(19):7439-44. doi: 10.1073/pnas.1200566109. Epub 2012 Apr 12.

6.

Virus-like particle secretion and genotype-dependent immunogenicity of dengue virus serotype 2 DNA vaccine.

Galula JU, Shen WF, Chuang ST, Chang GJ, Chao DY.

J Virol. 2014 Sep;88(18):10813-30. doi: 10.1128/JVI.00810-14. Epub 2014 Jul 9.

7.

The human antibody response to dengue virus infection.

Wahala WM, Silva AM.

Viruses. 2011 Dec;3(12):2374-95. doi: 10.3390/v3122374. Epub 2011 Nov 25. Review.

8.

Dengue virus infection and virus-specific HLA-A2 restricted immune responses in humanized NOD-scid IL2rgammanull mice.

Jaiswal S, Pearson T, Friberg H, Shultz LD, Greiner DL, Rothman AL, Mathew A.

PLoS One. 2009 Oct 5;4(10):e7251. doi: 10.1371/journal.pone.0007251.

9.

Dominant cross-reactive B cell response during secondary acute dengue virus infection in humans.

Zompi S, Montoya M, Pohl MO, Balmaseda A, Harris E.

PLoS Negl Trop Dis. 2012;6(3):e1568. doi: 10.1371/journal.pntd.0001568. Epub 2012 Mar 20.

10.

Dengue virus infection and immune response in humanized RAG2(-/-)gamma(c)(-/-) (RAG-hu) mice.

Kuruvilla JG, Troyer RM, Devi S, Akkina R.

Virology. 2007 Dec 5;369(1):143-52. Epub 2007 Aug 16.

11.

The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity.

Beltramello M, Williams KL, Simmons CP, Macagno A, Simonelli L, Quyen NT, Sukupolvi-Petty S, Navarro-Sanchez E, Young PR, de Silva AM, Rey FA, Varani L, Whitehead SS, Diamond MS, Harris E, Lanzavecchia A, Sallusto F.

Cell Host Microbe. 2010 Sep 16;8(3):271-83. doi: 10.1016/j.chom.2010.08.007.

12.

Manipulation of immunodominant dengue virus E protein epitopes reduces potential antibody-dependent enhancement.

Hughes HR, Crill WD, Chang GJ.

Virol J. 2012 Jun 18;9:115. doi: 10.1186/1743-422X-9-115.

13.

Correlation between dengue-specific neutralizing antibodies and serum avidity in primary and secondary dengue virus 3 natural infections in humans.

Puschnik A, Lau L, Cromwell EA, Balmaseda A, Zompi S, Harris E.

PLoS Negl Trop Dis. 2013 Jun 13;7(6):e2274. doi: 10.1371/journal.pntd.0002274. Print 2013.

14.

Dengue virus envelope protein domain I/II hinge determines long-lived serotype-specific dengue immunity.

Messer WB, de Alwis R, Yount BL, Royal SR, Huynh JP, Smith SA, Crowe JE Jr, Doranz BJ, Kahle KM, Pfaff JM, White LJ, Sariol CA, de Silva AM, Baric RS.

Proc Natl Acad Sci U S A. 2014 Feb 4;111(5):1939-44. doi: 10.1073/pnas.1317350111. Epub 2014 Jan 2. Erratum in: Proc Natl Acad Sci U S A. 2014 Apr 22;111(16):6115.

15.

The potent and broadly neutralizing human dengue virus-specific monoclonal antibody 1C19 reveals a unique cross-reactive epitope on the bc loop of domain II of the envelope protein.

Smith SA, de Alwis AR, Kose N, Harris E, Ibarra KD, Kahle KM, Pfaff JM, Xiang X, Doranz BJ, de Silva AM, Austin SK, Sukupolvi-Petty S, Diamond MS, Crowe JE Jr.

MBio. 2013 Nov 19;4(6):e00873-13. doi: 10.1128/mBio.00873-13.

16.
17.

Dengue virus neutralization by human immune sera: role of envelope protein domain III-reactive antibody.

Wahala WM, Kraus AA, Haymore LB, Accavitti-Loper MA, de Silva AM.

Virology. 2009 Sep 15;392(1):103-13. doi: 10.1016/j.virol.2009.06.037. Epub 2009 Jul 24.

18.

Analysis of human monoclonal antibodies generated by dengue virus-specific memory B cells.

Friberg H, Jaiswal S, West K, O'Ketch M, Rothman AL, Mathew A.

Viral Immunol. 2012 Oct;25(5):348-59. doi: 10.1089/vim.2012.0010. Epub 2012 Aug 30.

19.

DENV-2 subunit proteins fused to CR2 receptor-binding domain (P28)-induces specific and neutralizing antibodies to the Dengue virus in mice.

García-Machorro J, López-González M, Barrios-Rojas O, Fernández-Pomares C, Sandoval-Montes C, Santos-Argumedo L, Villegas-Sepúlveda N, Gutiérrez-Castañeda B, Cedillo-Barrón L.

Hum Vaccin Immunother. 2013 Nov;9(11):2326-35. Epub 2013 Jul 23.

20.

Human immune system development and survival of non-obese diabetic (NOD)-scid IL2rγ(null) (NSG) mice engrafted with human thymus and autologous haematopoietic stem cells.

Covassin L, Jangalwe S, Jouvet N, Laning J, Burzenski L, Shultz LD, Brehm MA.

Clin Exp Immunol. 2013 Dec;174(3):372-88. doi: 10.1111/cei.12180.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk